Sharon M. Moe

Sharon M. Moe

Auto-generated profile, based on publicly available information

Sharon M. Moe

Indiana University School of Medicine, United States

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2006 in Kidney International
Verified
Journal Article
Closed access
SMS. Moe
S. Moe
TDT. Drüeke
T. Drüeke
JCJ. Cunningham
J. Cunningham
WGW. Goodman
W. Goodman
KMK. Martin
K. Martin
GEG. Eknoyan
G. Eknoyan

1 February 2011 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
SMSharon M. Moe
Sharon M. Moe
MZMiriam P. Zidehsarai
Miriam P. Zidehsarai
MCMary A. Chambers
Mary A. Chambers
LJLisa A. Jackman
Lisa A. Jackman
JRJ. Scott Radcliffe
J. Scott Radcliffe
JAJohn R. Asplin
John R. Asplin
Summary: Background and objectives: Patients with advanced chronic kidney disease (CKD) are in positive phosphorus balance, but phosphorus levels are maintained in the normal range through phosphaturia induced by increases in fibroblast growth factor-23 (FGF23) and parathyroid hormone (PTH). This provides the rationale for recommendations to restrict dietary phosphate intake to 800 mg/d. However, the protein source of the phosphate may also be important. Design, setting, participants, & measurements: We conducted a crossover trial in nine patients with a mean estimated GFR of 32 ml/min to directly compare vegetarian and meat diets with equivalent nutrients prepared by clinical research staff. During the last 24 hours of each 7-day diet period, subjects were hospitalized in a research center and urine and blood were frequently monitored. Results: The results indicated that 1 week of a vegetarian diet led to lower serum phosphorus levels and decreased FGF23 levels. The inpatient stay demonstrated similar diurnal variation for blood phosphorus, calcium, PTH, and urine fractional excretion of phosphorus but significant differences between the vegetarian and meat diets. Finally, the 24-hour fractional excretion of phosphorus was highly correlated to a 2-hour fasting urine collection for the vegetarian diet but not the meat diet. Conclusions: In summary, this study demonstrates that the source of protein has a significant effect on phosphorus homeostasis in patients with CKD. Therefore, dietary counseling of patients with CKD must include information on not only the amount of phosphate but also the source of protein from which the phosphate derives.

17 September 2004 in Circulation Research
Verified
Journal Article
Closed access
PDF file
SMSharon M. Moe
Sharon M. Moe
NCNeal X. Chen
Neal X. Chen
Patients with chronic kidney disease (CKD) on dialysis have 2- to 5-fold more coronary artery calcification than age-matched individuals with angiographically proven coronary artery disease. In addition to increased traditional risk factors, CKD patients also have a number of nontraditional cardiovascular risk factors that may play a prominent role in the pathogenesis of arterial calcification, including duration of dialysis and disorders of mineral metabolism. In histological specimens from the inferior epigastric artery of dialysis patients, we have found expression of the osteoblast differentiation factor core binding factor α-1 (Cbfa1) and several bone-associated proteins (osteopontin, bone sialoprotein, alkaline phosphatase, type I collagen) in both the intima and medial layers when calcification was present. In cultured vascular smooth muscle cells, the addition of pooled serum from dialysis patients (versus normal healthy controls) accelerated mineralization and increased expression of Cbfa1, osteopontin, and alkaline phosphatase to a similar magnitude as does β-glycerophosphate alone. However, a lack of inhibitors of calcification may also be important. Dialysis patients with low levels of serum fetuin-A, a circulating inhibitor of mineralization, have increased coronary artery calcification and fetuin-A can inhibit mineralization of vascular smooth muscle cells in vitro. These data support that elevated levels of phosphorus and/or other potential uremic toxins may play an important role by transforming vascular smooth muscle cells into osteoblast-like cells, which can produce a matrix of bone collagen and noncollagenous proteins. This nidus can then mineralize if the balance of pro-mineralizing factors outweighs inhibitory factors.

1 February 2008 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
SMSharon M. Moe
Sharon M. Moe
NCNeal X. Chen
Neal X. Chen
Vascular calcification is common in chronic kidney disease and associated with increased morbidity and mortality. Its mechanism is multifactorial and incompletely understood. Patients with chronic kidney disease are at risk for vascular calcification because of multiple risk factors that induce vascular smooth muscle cells to change into a chondrocyte or osteoblast-like cell; high total body burden of calcium and phosphorus due to abnormal bone metabolism; low levels of circulating and locally produced inhibitors; impaired renal excretion; and current therapies. Together these factors increase risk and complicate the management of vascular calcification.

1 February 2002 in Kidney International
Verified
Journal Article
Closed access
SMSharon M. Moe
Sharon M. Moe
KOKalisha D. O'Neill
Kalisha D. O'Neill
DDDanxia Duan
Danxia Duan
SASadiq Ahmed
Sadiq Ahmed
NCNeal X. Chen
Neal X. Chen
KKKenyon Kopecky
Kenyon Kopecky

1 June 2005 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
RLRobert E. LaClair
Robert E. LaClair
RHRichard N. Hellman
Richard N. Hellman
SKSharon L. Karp
Sharon L. Karp
MKMichael Kraus
Michael Kraus
SOSusan Ofner
Susan Ofner
SMSharon M. Moe
Sharon M. Moe